Demographic | Value |
---|---|
Number of patients | 107 |
Age (years) | 49 ± 11 |
BMI (kg/m2) | 57.8 ± 9.2 |
Female | 77 (72.0) |
Race | |
White | 54 (50.5) |
More Than One Race | 19 (17.8) |
Unknown/Not Reported (includes Hispanic or Latino) | 16 (15.0) |
Black or African American | 15 (14.0) |
Native Hawaiian or Other Pacific Island | 2 (1.9) |
American Indian/Alaska Native | 1 (0.9) |
Smoking | 9 (8.4) |
Comorbidities & VTE Risk Factors | |
Obstructive sleep apnea | 67 (62.2) |
Mobility limitations | 34 (31.8) |
Asthma | 24 (22.4) |
Prior VTE | 24 (22.4) |
Chronic venous insufficiency | 13 (12.2) |
Peripheral vascular disease | 3 (2.8) |
Thrombophilia | 3 (2.8) |
Home oxygen | 1 (0.9) |
Home medications | |
Aspirin | 12 (11.2) |
Warfarin | 8 (7.5) |
Other oral anticoagulant | 3 (2.8) |
Enoxaparin | 0 (0.0) |